CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • How COVID-19 is Impacting Care for Blood Cancer Patients

    CRI spoke with Dr. Melody Smith about how clinical care for leukemia, lymphoma, and multiple myeloma patients…

    May 8, 2020| Arthur N. Brodsky, PhD
  • How COVID-19 is Impacting Care for Lung Cancer Patients

    CRI spoke with Dr. Joshua Sabari about how clinical care for lung cancer patients has been impacted…

    May 7, 2020| Arthur N. Brodsky, PhD
  • Analytical Strategies in Immunology for Cancer and COVID-19 with Dr. Katie Campbell

    Dr. Campbell’s work as a CRI fellow at UCLA is improving our understanding of both cancer and…

    May 6, 2020| Arthur N. Brodsky, PhD
  • Cancer, COVID-19, and the Immune Genome with Dr. Brian Brown

    CRI Technology Impact Award recipient Dr. Brian Brown has been developing a technology to help us better…

    May 5, 2020| Arthur N. Brodsky, PhD
  • Melanoma Monday: 2020 Immunotherapy Research Update

    Bringing immunotherapy earlier into treatment, extraordinary patient journeys, and how we’re working toward a future immune to…

    May 4, 2020| CRI Staff
  • Melanoma and Immunotherapy: Tara’s Journey to Become a Cancer Patient Advocate

    Melanoma veteran Tara Ryan shares her experience with taking control of her health, resilience in the face…

    May 4, 2020| Caroline Offit
  • AACR20 Day 2 Highlights: COVID-19, Adoptive Cell Therapy, and Checkpoint Immunotherapy Insights

    The second day of AACR’s annual meeting heard from experts at cancer centers in COVID-19 hotspots around…

    April 29, 2020| Arthur N. Brodsky, PhD
  • AACR20 Day 1 Highlights: Breast Cancer, Lung Cancer, and the Microbiome

    The first day of the 2020 AACR Annual Meeting shared latest data from immunotherapy clinical trials in…

    April 28, 2020| Arthur N. Brodsky, PhD
  • Esophageal Cancer Awareness Month: 2020 Immunotherapy Research Update

    Promising new research, a variety of immunotherapy treatment combinations, and how we’re working toward a future immune…

    April 28, 2020| CRI Staff
Previous Page
1 … 35 36 37 38 39 … 92
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute